A carregar...
Genome-Wide Association Study of Treatment Response to Venlafaxine XR in Generalized Anxiety Disorder
We conducted the first genome-wide association study (GWAS) in Generalized Anxiety Disorder (GAD) to identify potential predictors of venlafaxine XR treatment outcome. Ninety-eight European Americans (EA) patients participated in a venlafaxine XR clinical trial for GAD, with Hamilton Anxiety Scale (...
Na minha lista:
| Publicado no: | Psychiatry Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5798606/ https://ncbi.nlm.nih.gov/pubmed/28437668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.psychres.2017.04.025 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|